Philip Morris International Inc. (PMI) to Host Webcast of 2023 First-Quarter Results
April 13 2023 - 11:57AM
Business Wire
Regulatory News:
Philip Morris International Inc. (NYSE: PM) will host a live
audio webcast at www.pmi.com/2023Q1earnings on Thursday, April 20,
2023, at 9:00 a.m. ET, to discuss its 2023 first-quarter results,
which will be issued at approximately 7:00 a.m. ET the same
day.
The webcast will be hosted by Emmanuel Babeau, PMI’s Chief
Financial Officer, and will include a discussion of PMI’s financial
results, as well as a question-and-answer session with the
investment community and news media. The webcast will be in a
listen-only mode.
The audio webcast may also be accessed on iOS or Android devices
by downloading PMI’s free Investor Relations Mobile Application at
www.pmi.com/irapp.
An archived copy of the webcast will be available until 5:00
p.m. ET on Friday, May 19, 2023, at www.pmi.com/2023Q1earnings.
Slides and script will also be available at
www.pmi.com/2023Q1earnings.
Philip Morris International: Delivering a Smoke-Free
Future
Philip Morris International (PMI) is a leading international
tobacco company working to deliver a smoke-free future and evolving
its portfolio for the long term to include products outside of the
tobacco and nicotine sector. The company’s current product
portfolio primarily consists of cigarettes and smoke-free products.
Since 2008, PMI has invested more than USD 10.5 billion to develop,
scientifically substantiate and commercialize innovative smoke-free
products for adults who would otherwise continue to smoke, with the
goal of completely ending the sale of cigarettes. This includes the
building of world-class scientific assessment capabilities, notably
in the areas of pre-clinical systems toxicology, clinical and
behavioral research, as well as post-market studies. In November
2022, PMI acquired Swedish Match – a leader in oral nicotine
delivery – creating a global smoke-free champion led by the
companies’ IQOS and ZYN brands. The U.S. Food and Drug
Administration (FDA) has authorized versions of PMI’s IQOS Platform
1 devices and consumables and Swedish Match’s General snus as
Modified Risk Tobacco Products (MRTPs). As of December 31, 2022,
PMI's smoke-free products were available for sale in 73 markets,
and PMI estimates that approximately 17.8 million adults around the
world had already switched to IQOS and stopped smoking. Smoke-free
products accounted for approximately 32% of PMI’s total full-year
2022 net revenues. With a strong foundation and significant
expertise in life sciences, PMI announced in February 2021 its
ambition to expand into wellness and healthcare areas and, through
its Vectura Fertin Pharma subsidiary, aims to enhance life through
the delivery of seamless health experiences. For more information,
please visit www.pmi.com and pmiscience.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230413005571/en/
Investor Relations: Stamford, CT: +1 (203) 904 2410 Lausanne:
+41 (0)58 242 4666 Email: InvestorRelations@pmi.com
Media: David Fraser Lausanne: +41 (0)58 242 4500 Email:
David.Fraser@pmi.com
Philip Morris (NYSE:PM)
Historical Stock Chart
From Mar 2024 to Apr 2024
Philip Morris (NYSE:PM)
Historical Stock Chart
From Apr 2023 to Apr 2024